scholarly article | Q13442814 |
P2093 | author name string | Ping-Jyun Sung | |
Wei-Hsien Wang | |||
Yueh-Hsiung Kuo | |||
Che-Yi Chao | |||
P2860 | cites work | Alterations in tissue glucose uptake during the hyperglycemic and hypoglycemic phases of sepsis | Q73780931 |
Inhibition of heme oxygenase ameliorates sepsis-induced liver dysfunction in rats | Q78865172 | ||
Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators | Q24652367 | ||
Human and rat peroxisome proliferator activated receptors (PPARs) demonstrate similar tissue distribution but different responsiveness to PPAR activators | Q28241939 | ||
Nitric oxide and the immune response | Q29617591 | ||
The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation | Q29620219 | ||
Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation | Q34088380 | ||
Nitric oxide synthase 2 and cyclooxygenase 2 interactions in inflammation | Q34242689 | ||
Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation | Q34338138 | ||
Secretory products of macrophages | Q34557411 | ||
Regulation of cytokine signaling and inflammation | Q34830660 | ||
Bitter gourd (Momordica Charantia): A dietary approach to hyperglycemia | Q36566356 | ||
Molecular mechanism of PPAR in the regulation of age-related inflammation | Q37099509 | ||
Immunomodulatory role of PPAR-gamma in alveolar macrophages | Q37101176 | ||
Anti-diabetic and hypoglycaemic effects of Momordica charantia (bitter melon): a mini review | Q37613790 | ||
Bitter gourd suppresses lipopolysaccharide-induced inflammatory responses | Q38290827 | ||
Peroxisome proliferator-activated receptor mediates induction of the mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase gene by fatty acids | Q38306159 | ||
Wild bitter melon (Momordica charantia Linn. var. abbreviata Ser.) extract and its bioactive components suppress Propionibacterium acnes-induced inflammation | Q39284443 | ||
Isolation and identification of cucurbitane-type triterpenoids with partial agonist/antagonist potential for estrogen receptors from Momordica charantia | Q39566463 | ||
Bitter gourd seed fatty acid rich in 9c,11t,13t-conjugated linolenic acid induces apoptosis and up-regulates the GADD45, p53 and PPARgamma in human colon cancer Caco-2 cells. | Q39614890 | ||
Fractionation and identification of 9c, 11t, 13t-conjugated linolenic acid as an activator of PPARalpha in bitter gourd (Momordica charantia L.). | Q40235127 | ||
Bitter gourd (Momordica charantia) extract activates peroxisome proliferator-activated receptors and upregulates the expression of the acyl CoA oxidase gene in H4IIEC3 hepatoma cells | Q40614722 | ||
Differential effects of foods traditionally regarded as 'heating' and 'cooling' on prostaglandin E(2) production by a macrophage cell line | Q40690056 | ||
Cardiac and regional haemodynamics, inducible nitric oxide synthase (NOS) activity, and the effects of NOS inhibitors in conscious, endotoxaemic rats | Q42708544 | ||
Wild bitter gourd extract up-regulates mRNA expression of PPARα, PPARγ and their target genes in C57BL/6J mice | Q42746495 | ||
Liver in systemic disease | Q42952131 | ||
Effect of Momordica charantia on the glucose tolerance in maturity onset diabetes | Q44509994 | ||
Suppressive effects of wild bitter gourd (Momordica charantia Linn. var. abbreviata ser.) fruit extracts on inflammatory responses in RAW264.7 macrophages | Q46069573 | ||
Extracts of Momordica charantia suppress postprandial hyperglycemia in rats. | Q46803099 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 8 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | sepsis | Q183134 |
Momordica charantia | Q428750 | ||
P304 | page(s) | 12777-12788 | |
P577 | publication date | 2014-08-21 | |
P1433 | published in | Molecules | Q151332 |
P1476 | title | Anti-inflammatory effect of Momordica charantia in sepsis mice | |
P478 | volume | 19 |
Q64257123 | , a Nutraceutical Approach for Inflammatory Related Diseases |
Q60921127 | Administration of Enhances the Neuroprotection and Reduces the Side Effects of LiCl in the Treatment of Alzheimer's Disease |
Q33630853 | An Update Review on the Anthelmintic Activity of Bitter Gourd, Momordica charantia |
Q92151756 | Bitter gourd (Momordica charantia) possess developmental toxicity as revealed by screening the seeds and fruit extracts in zebrafish embryos |
Q58607934 | Bitter melon (Momordica charantia) attenuates atherosclerosis in apo-E knock-out mice possibly through reducing triglyceride and anti-inflammation |
Q28817944 | Bitter melon: a panacea for inflammation and cancer |
Q48275920 | Effectiveness of Antihyperglycemic Effect of Momordica charantia: Implication of T-Cell Cytokines |
Q58134111 | Fermented bitter gourd extract differentially regulates lipopolysaccharide-induced cytokine gene expression through nuclear factor-κB and interferon regulatory factor-1 |
Q40811755 | Inhibitory effects of wild bitter melon leaf extract on Propionibacterium acnes-induced skin inflammation in mice and cytokine production in vitro |
Q53078455 | Medically important carotenoids from Momordica charantia and their gene expressions in different organs. |
Q47432678 | Momordica charantia extracts ameliorate insulin resistance by regulating the expression of SOCS-3 and JNK in type 2 diabetes mellitus rats |
Q36865059 | Pro-inflammatory effects of a litchi protein extract in murine RAW264.7 macrophages |
Q47356636 | Recent Advances in Momordica charantia: Functional Components and Biological Activities |
Search more.